SCHEMBL7549871

SCHEMBL7549871

C[C@](CC(=O)O)(c1ccc(Cl)cc1)C1CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.54
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
CYP2C19 P33261 3/20 0.40
HIF1A Q16665 1/20 0.40
POLB P06746 1/20 0.39
CYP19A1 P11511 1/20 0.39
TSHR P16473 1/20 0.37
CYP1A2 P05177 2/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7548234 1.00 MIF (0.54) MIFKMT2AMEN1CYP2C19HIF1A
SCHEMBL8402081 0.78 RAB9A (0.42) CYP2C19HIF1ACYP1A2MAPTSMN1; SMN2
SCHEMBL13471820 0.78 PTGDR (0.39) MIFKMT2AMEN1CYP2C19POLB
SCHEMBL9076603 0.78 MIF (0.63) MIFKMT2AMEN1CYP2C19HIF1A
SCHEMBL8922034 0.77 CYP2C19 (0.51) CYP2C19HIF1APOLBCYP2D6
SCHEMBL27276208 0.76 MEN1 (0.41) KMT2AMEN1CYP2C19POLBCYP19A1
SCHEMBL24020497 0.75 MIF (0.66) MIFKMT2AMEN1CYP2C19HIF1A
SCHEMBL8476286 0.75 CYP2C19 (0.68) MIFKMT2AMEN1CYP2C19HIF1A
SCHEMBL987076 0.75 MIF (0.66) MIFKMT2AMEN1CYP2C19HIF1A
SCHEMBL2504417 0.75 CYP2C19 (0.45) CYP2C19HIF1APOLBCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032351-A1 Process for the preparation of chiral isofluoroenes BASF AKTIENGESELLSCHAFT (DE) 2002-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032351-A1 Process for the preparation of chiral isofluoroenes CYP51A1, CYP4F11, CYP2F1 MIF 1060/4885KMT2A 4495/4885MEN1 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.